within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10B_BloodGlucoseLoweringDrugsExclInsulins.A10BJ01_Exenatide;

model Exenatide
  extends Pharmacolibrary.Drugs.ATC.A.A10BJ01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A10BJ01</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Exenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is available in both twice-daily injection (Byetta) and long-acting once-weekly (Bydureon) formulations. Exenatide is approved and widely used today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported from healthy subjects and patients with type 2 diabetes after subcutaneous administration of 5 or 10 mcg exenatide. Single- and multiple-dose two-compartment models have been used. Data below reflect findings from key clinical studies and FDA labeling references.</p><h4>References</h4><ol><li><p>Hall, S, et al., &amp; Clements, JN (2018). Pharmacokinetics and Clinical Implications of Semaglutide: A New Glucagon-Like Peptide (GLP)-1 Receptor Agonist. <i>Clinical pharmacokinetics</i> 57(12) 1529–1538. DOI:<a href=\"https://doi.org/10.1007/s40262-018-0668-z\">10.1007/s40262-018-0668-z</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29915923/\">https://pubmed.ncbi.nlm.nih.gov/29915923</a></p></li><li><p>Cirincione, B, &amp; Mager, DE (2017). Population pharmacokinetics of exenatide. <i>British journal of clinical pharmacology</i> 83(3) 517–526. DOI:<a href=\"https://doi.org/10.1111/bcp.13135\">10.1111/bcp.13135</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27650681/\">https://pubmed.ncbi.nlm.nih.gov/27650681</a></p></li><li><p>Vlasakakis, G, et al., &amp; Nunez, DJ (2015). Pharmacokinetics and Tolerability of Exenatide Delivered by 7-Day Continuous Subcutaneous Infusion in Healthy Volunteers. <i>Advances in therapy</i> 32(7) 650–661. DOI:<a href=\"https://doi.org/10.1007/s12325-015-0222-4\">10.1007/s12325-015-0222-4</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26160357/\">https://pubmed.ncbi.nlm.nih.gov/26160357</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Exenatide;
